Top Stories
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
/ read more /
The agency has release a report providing an overview of steps taken to enhance benefit-risk assessment in the review of drugs.
/ read more /
|
|
INTERPHEX 2018 Keynote Series
Aseptic, Sterile, and Biologics Drug Manufacturing
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
LEARN MORE
|
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
Industry News
A new scientific publication examines analytical processes for the emerging legal cannabis industry.
/ read more /
Congress passed a $1.3-trillion omnibus budget bill March 22, 2018 that increases federal support for biomedical research and health programs for fiscal year 2018.
/ read more /
More Industry News
|
|
|
|
Supplier News
MedPharm has received a multi-million dollar investment by Ampersand Capital Partners to diversify its service offering and regional coverage.
/ read more /
The company has developed an intelligent laminate for supply chain security and traceability in addition to a new business unit that develops intelligent hyperspectral imaging solutions.
/ read more /
More Supplier News
|
|
|
Bio/Pharma News
Takeda is considering approaching Shire with a possible offer.
/ read more /
Novartis’ Sandoz is seeking approval of its biosimilar referencing Johnson & Johnson’s Remicade (infliximab) for all of Remicade’s indications across gastroenterology, rheumatology, and dermatology.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
The agency has accepted AstraZeneca's biologics license application for an investigational leukemia drug candidate and granted it priority review.
/ read more /
EMA has recommended approval of the biosimilar for the same indications as Roche’s Herceptin (trastuzumab).
/ read more /
More Regulatory News
|
|
|
|
|
QC/QA
A previously published article presented difficulties with the revised European guidelines on sterile manufacturing. The authors included a brief summary of the comments developed on the draft document. This article expands upon that summary, outlines the authors' rationale, and highlights the most difficult aspects of the revision draft.
/ read more /
|
|
|
|
DRUG DEVELOPMENT
Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
/ read more /
|
|
|
|
STANDARDS & REGULATIONS
Certificates of analysis can be used to monitor the reliability of products and their suppliers, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
/ read more /
|
|
|
Events
April 17–19, 2018
April 24–26, 2018
June 4–7, 2018
more events |
|
|
eBOOKS
 |
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible. |
|
|
|
|
|
